Lanreotide Impurity H

IMPURITIES

Product Details

CAT No.# CS-O-33428
Category Impurities
CAS 109605-17-6
Molecular Weight 1138.36
Molecular Formula C56H71N11O11S2
Purity: >98
Synonyms: (4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-acetamido-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide; N-​acetyl-​3-​(2-​naphthalenyl)​-​D-​alanyl-​L-​cysteinyl-​L-​tyrosyl-​D-​tryptophyl-​L-​lysyl-​L-​valyl-​L-​cysteinyl-​L-​Threoninamide cyclic (2→7)​-​disulfide; Ac-D-2-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 Cys-Cys
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. Lanreotide Impurity I
2. Dexamethasone Impurity 10
3. 2-chloro-5-(2-chloro-1-hydroxyethyl)phenol
4. 2-chloro-3-(2-chloro-1-hydroxyethyl)phenol
5. 3-(2,2-dichloro-1-hydroxyethyl)phenol
6. 3-(2-chloro-1-hydroxyethyl)phenol
7. 4-chloro-3-(2-chloro-1-hydroxyethyl)phenol
8. (R)-3-(2-chloro-1-hydroxyethyl)phenol
9. 2,2-dichloro-1-(3-hydroxyphenyl)ethanone
10. Metaraminol
11. Mebetide
12. 7-methoxy-3-methyl-2H-1,2,4-benzothidiazine 1, 1-dioxide
13. (R)-4-chloro-3-(1-hydroxy-2-(methylamino)ethyl)phenol
14. (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-2-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
15. Tedisamil
16. Cefroxadine
17. Jatamansone
18. Clorazepate-D5
19. 5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-6,7-dihydrothieno[3,2-c]pyridin-5-ium
20. Telmesteine


SMILES:
O=C(N[C@@](C(N[C@H]1C(C)C)=O)([H])CCCCN)[C@H](NC([C@@H](NC([C@@](CSSC[C@@H](C(N[C@H](C(N)=O)[C@H](O)C)=O)NC1=O)([H])NC([C@H](NC(C)=O)CC2=CC3=CC=CC=C3C=C2)=O)=O)CC4=CC=C(O)C=C4)=O)CC5=CNC6=C5C=CC=C6



This page contains information about Lanreotide Impurity H Cas 109605-17-6 and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."